Nitrogen containing heterocycles as anticancer agents: a medicinal chemistry perspective

A Kumar, AK Singh, H Singh, V Vijayan, D Kumar… - Pharmaceuticals, 2023 - mdpi.com
Cancer is one of the major healthcare challenges across the globe. Several anticancer
drugs are available on the market but they either lack specificity or have poor safety, severe …

An overview of quinazolines: Pharmacological significance and recent developments

V Alagarsamy, K Chitra, G Saravanan… - European journal of …, 2018 - Elsevier
Most of the drugs and pharmacologically relevant molecules possess heterocyclic ring
structures and presence of hetero atoms or groupings divulges privileged specificities in …

Pyrimidine: a review on anticancer activity with key emphasis on SAR

A Mahapatra, T Prasad, T Sharma - Future journal of pharmaceutical …, 2021 - Springer
Background Cancer is a global health challenge, it impacts the quality of life and its
treatment is associated with several side effects. Resistance of the cancer cells to the …

Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019)

P Bhatia, V Sharma, O Alam, A Manaithiya… - European Journal of …, 2020 - Elsevier
The over expression of EGFR has been recognized as the driver mechanism in the
occurrence and progression of carcinomas such as lung cancer, breast cancer, pancreatic …

An appraisal of anticancer activity with structure–activity relationship of quinazoline and quinazolinone analogues through EGFR and VEGFR inhibition: A review

K Haider, S Das, A Joseph… - Drug Development …, 2022 - Wiley Online Library
Cancer is one of the leading causes of death. Globally a huge number of deaths and new
incidences are reported annually. Heterocyclic compounds have been proved to be very …

Synthesis of novel pyrido [2, 3-d] pyrimidine-thiazolidine-1, 2, 3-triazoles: Potent EGFR targeting anticancer agents

SR Bandi, R Kapavarapu, R Palabindela… - Journal of Molecular …, 2023 - Elsevier
In this study, we designed and synthesized a number of novel pyrido [2, 3-d] pyrimidine-
thiazolidine-1, 2, 3-triazole derivatives and investigated them in vitro for their inhibitory …

Novel click modifiable thioquinazolinones as anti-inflammatory agents: Design, synthesis, biological evaluation and docking study

G Moussa, R Alaaeddine, LM Alaeddine… - European journal of …, 2018 - Elsevier
Click chemistry was used to synthesize a new series of thioquinazolinone molecules
equipped with propargyl moiety, 1, 2, 3-triazolyl and isoxazolyl rings. Our design was based …

Modified pyrido [2, 3-d] pyrimidin-4 (3H)-one derivatives as EGFRWT and EGFRT790M inhibitors: Design, synthesis, and anti-cancer evaluation

ES Nossier, RA Alasfoury, M Hagras… - Journal of Molecular …, 2022 - Elsevier
This study reports design and synthesis of thirteen pyrido [2, 3-d] pyrimidin-4 (3H)-one
derivatives as EGFR inhibitors. The antiproliferation activities were tested for all compounds …

A review on fused pyrimidine systems as EGFR inhibitors and their structure–activity relationship

TT Yadav, G Moin Shaikh, MS Kumar… - Frontiers in …, 2022 - frontiersin.org
Epidermal growth factor receptor (EGFR) belongs to the family of tyrosine kinase that is
activated when a specific ligand binds to it. The EGFR plays a vital role in the cellular …

New quinazolinone‐based derivatives as DHFR/EGFR‐TK inhibitors: synthesis, molecular modeling simulations, and anticancer activity

YI El‐Gazzar, HR Ghaiad, AM El Kerdawy… - Archiv der …, 2023 - Wiley Online Library
Abstract New 2‐mercapto‐quinazolin‐4‐one analogs were synthesized and tested for their
in vitro anticancer activity, dihydrofolate reductase (DHFR) inhibition, and epidermal growth …